Biochemical and genetic evidence for complex formation between the influenza a virus NS1 protein and the interferon-induced PKR protein kinase

Journal of Interferon and Cytokine Research

Volumn 18, Issue 9, 1998, Pages 757-766

  Tan, Seng Lai ^a   Katze, Michael G ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; COMPLEX FORMATION; DIMERIZATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; TRANSLATION INITIATION; VIRUS INFECTION; VIRUS REPLICATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS A; PYRONIA TITHONUS;

EID: 0031670374     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.757     Document Type: Article

References (74)

1. SAMUEL, C.E. (1993). The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268, 7603-7606.
2. CLEMENS, M.J., and ELIA, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17, 503-524.
3. KUMAR, A., HAQUE, J., LACOSTE, J., HISCOTT, J., and WILLIAMS, B.R.G. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating 1 kappa B. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
4. KUMAR, A., YANG, Y.L., FLATI, V., DER, S., KADEREIT, S., DEB, A., HAQUE, J., REIS, L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappa B. EMBO J. 16, 406-416.
5. KIRCHHOFF, S., KOROMILAS, A.E., SCHAFER, F., GRASHOFF, M., SONENBERG, N., and HAUSER, H. (1995). IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11, 439-445.
6. BERETTA, L., GABBAY, M., BERGER, R., HANASH, S.M., and SONENBERG, N. (1996). Expression of the protein kinase PKR is modulated by IRF-1 and is reduced in 5q-associated leukemias. Oncogene 12, 1593-1596.
7. LEE, S.B., and ESTEBAN, M. (1994). The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-196.
8. YEUNG, M.C., LIU, J., and LAU, A.S. (1996). An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. USA 93, 12451-12455.
9. DER, S.D., YANG, Y.L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
10. SRIVASTAVA, S.P., KUMAR, K.U., and KAUFMAN, R.J. (1998). Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 273, 2416-2423.
11. SONENSHEIN, G.E. (1997). ReI/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119.
12. TANIGUCHI, T., LAMPHIER, M.S., and TANAKA, N. (1997). IRF-1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta 1333, M9-17.
13. KOROMILAS, A.E., ROY, S., BARBER, G.N., KATZE, M.G., and SONENBERG, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
14. CHONG, K.L., FENG, L., SCHAPPERT, K., MEURS, E., DONAHUE, T.F., FRIESEN, J.D., HOVANESSIAN, A.G., and WILLIAMS, B.R.G. (1992). Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11, 1553-1562.
15. MEURS, E., GALABRU, J., BARBER, G.N., KATZE, M.G., and HOVANESSIAN, A.G. (1993). Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 90, 232-236.
16. BARBER, G.N., WAMBACH, M., THOMPSON, S., JAGUS, R., and KATZE, M.G. (1995). Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15, 3138-3146.
17. KATZE, M.G. (1995). Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol. 3, 75-78.
18. JACOBS, B.L., and LANGLAND, J.O. (1997). Viral inhibitors of interferon action: inhibitors of the PKR and 2′5′ oligoadenylate synthetase/RNase L pathways. Gamma Interferon in Antiviral Defense 192, 155-173.
19. r protein kinase to regulate its autophosphorylation and activity. EMBO J. 6, 689-697.
20. DAVIES, M.V., CHANG, H.W., JACOBS, B.L., and KAUFMAN, R.J. (1993). The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67, 1688-1692.
21. LLOYD, R.M., and SHATKIN, A.J. (1992). Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 6878-6884.
22. r protein kinase. J. Virol. 65, 632-640.
23. PARK, H., DAVIES, M.V., LANGLAND, J.O., CHANG, H.W., NAM, Y.S., TARTAGLIA, J., PAOLETTI, E., JACOBS, B.L., KAUFMAN, R.J., and VENKATESAN, S. (1994). TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA 91, 4713-4717.
24. BRAND, S.R., KOBAYASHI, R., and MATHEWS, M.B. (1997). The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272, 8388-8395.
25. r protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J. Virol. 63, 2244-2251.
26. ROY, S., KATZE, M.G., PARKIN, N.T., EDERY, I., HOVANESSIAN, A.G., and SONENBERG, N. (1990). Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247, 1216-1219.
27. IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation. Mol. Cell. Biol. 16, 4172-4181.
28. IPK inhibitor. Mol. Cell. Biol. 18, 2431-2443.
29. GALE, M.J., Jr., KORTH, M.J., TANG, N.M., TAN, S.-L., HOPKINS, D.A., DEVER, T.E., POLYAK, S.J., GRETCH, D.R., and KATZE, M.G. (1997). Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227.
30. HE, B., GROSS, M., and ROIZMAN, B. (1997). The gamma(1) 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94, 843-848.
31. RANDAZZO, B.P., TAL SINGER, R., ZABOLOTNY, J.M., KESARI, S., and FRASER, N.W. (1997). Herpes simplex virus 1716, an ICP 34.5 null mutant, is unable to replicate in CV-1 cells due to a translational block that can be overcome by coinfection with SV40. J. Gen. Virol. 78, 3333-3339.
32. SWAMINATHAN, S., RAJAN, P., SAVINOVA, O., JAGUS, R., and THIMMAPAYA, B. (1996). Simian virus 40 large-T bypasses the translational block imposed by the phosphorylation of e1F-2 alpha. Virology 219, 321-323.
33. RAJAN, P., SWAMINATHAN, S., ZHU, J., COLE, C.N., BARBER, G., TEVETHIA, M.J., and THIMMAPAYA, B. (1995). A novel translational regulation function for the simian virus 40 large-T antigen gene. J. Virol. 69, 785-795.
34. LU, Y., WAMBACH, M., KATZE, M.G., and KRUG, R.M. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the e1F-2 translation initiation factor. Virology 214, 222-228.
35. IPK, the cellular inhibitor of PKR. Proc. Natl. Acad. Sci. USA 94, 97-102.
36. rIPK. Mol. Cell. Biol. 18, 859-871.
37. SCHIESTL, R.H., and GIETZ, R.D. (1989). High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16, 339-346.
38. BOHEN, S.P., and YAMAMOTO, K.R. (1993). Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc. Natl. Acad. Sci. USA 90, 11424-11428.
39. ROMANO, P.R., GREEN, S.R., BARBER, G.N., MATHEWS, M.B., and HINNEBUSCH, A.G. (1995). Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 365-378.
40. r protein kinase in a cell-free system. Mol. Cell Biol. 11, 5497-5505.
41. TANG, N.M., HO, C.Y., and KATZE, M.G. (1996). The 58-kDa cellular inhibitor of the double stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ motifs to stimulate protein synthesis in vivo. J. Biol. Chem. 271, 28660-28666.
42. SMITH, D.B., and JOHNSON, K.S. (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
43. COSENTINO, G.P., VENKATESAN, S., SERLUCA, F.C., GREEN, S.R., MATHEWS, M.B., and SONENBERG, N. (1995). Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA 92, 9445-9449.
44. BENKIRANE, M., NEUVEUT, C., CHUN, R.F., SMITH, S.M., SAMUEL, C.E., GATIGNOL, A., and JEANG, K.T. (1997). Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16, 611-624.
45. KATZE, M.G., and KRUG, R.M. (1990). Translational control in influenza virus-infected cells. Enzyme 44, 265-277.
46. FIELDS, S., and SONG, O. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
47. PATEL, R.C., STANTON, P., MCMILLAN, N.M., WILLIAMS, B.R.G., and SEN, G.C. (1995). The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92, 8283-8287.
48. ORTEGA, L.G., MCCOTTER, M.D., HENRY, G.L., MCCORMACK, S.J., THOMIS, D.C., and SAMUEL, C.E. (1996). Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology 215, 31-39.
49. NEMEROFF, M.E., QIAN, X.Y., and KRUG, R.M. (1995). The influenza virus NS1 protein forms multimers in vitro and in vivo. Virology 212, 422-428.
50. BARBER, G.N., JAGUS, R., MEURS, E.F., HOVANESSIAN, A.G., and KATZE, M.G. (1995). Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270, 17423-17428.
51. HANKS, S.K., QUINNE, A.M., and HUNTER, T. (1988). The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42-52.
52. QIU, Y., and KRUG, R.M. (1994). The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68, 2425-2432.
53. LU, Y., QIAN, X.Y., and KRUG, R.M. (1994). The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 8, 1817-1828.
54. HATADA, E., and FUKUDA, R. (1992). Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325-3329.
55. MCMILLAN, N.A., CARPICK, B.W., HOLLIS, B., TOONE, W.M., ZAMANIAN-DARYOUSH, M., and WILLIAMS, B.R. (1995). Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. J. Biol. Chem. 270, 2601-2606.
56. PATEL, R.C., STANTON, P., and SEN, G.C. (1996). Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271, 25657-25663.
57. ENAMI, K., SATO, T.A., NAKADA, S., and ENAMI, M. (1994). Influenza virus NS1 protein stimulates translation of the M1 protein. J. Virol. 68, 1432-1437.
58. DE LA LUNA, S., FORTES, P., BELOSO, A., and ORT'IN, J. (1995). Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69, 2427-2433.
59. RICE, A.P., KOSTURA, M., and MATHEWS, M.B. (1989). Identification of a 90-kDA polypeptide which associates with adenovirus VA RNAI and is phosphorylated by the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 264, 20632-20637.
60. MUNDSCHAU, L.J., and FALLER, D.V. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270, 3100-3106.
61. PROSTKO, C.R., DHOLAKIA, J.N., BROSTROM, M.A., and BROSTROM, C.O. (1995). Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores. J. Biol. Chem. 270, 6211-6215.
62. PETRYSHYN, R., CHEN, J.J., and LONDON, I.M. (1988). Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc. Natl. Acad. Sci. USA 85, 1427-14231.
63. RAGER, K.J., LANGLAND, J.O., JACOBS, B.L., PROUD, D., MARSH, D.G., and IMANI, F. (1998). Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J. Virol. 72, 1171-1176.
64. DUBOIS, M.F., and HOVANESSIAN, A.G. (1990). Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection. Virology 179, 591-598.
65. JIM'ENEZ-GARC'IA, L.F., GREEN, S.R., MATHEWS, M.B., and SPECTOR, D.L. (1993). Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J. Cell Sci. 106, 11-22.
66. JEFFREY, I.W., KADEREIT, S., MEURS, E.F., METZGER, T., BACHMANN, M., SCHWEMMLE, M., HOVANESSIAN, A.G., and CLEMENS, M.J. (1995). Nuclear localization of the interferoninducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218, 17-27.
67. LAZAROWITZ, S.G., COMPANS, R.W., and CHOPPIN, P.W. (1971). Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology 46, 830-843.
68. KORTH, M.J., LYONS, C.N., WAMBACH, M., and KATZE, M.G. (1996). Cloning, expression, and cellular localization of the oncogenic 58-kDa inhibitor of the RNA-activated human and mouse protein kinase. Gene 170, 181-188.
69. TAKIZAWA, T., OHASHI, K., and NAKANISHI, Y. (1996). Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70, 8128-8132.
70. SCHULTZ-CHERRY, S., DYBDAHL-SISSOKO, N., LU, X.G., YIN, C.-Y., KRUG, R., and HINSHAW, V.S. (1997). Induction of apoptosis by individual influenza virus genes. American Society for Virology 16th Annual Meeting, W19-5.
71. LUDWIG, S., VOGEL, U., and SCHOLTISSEK, C. (1995). Amino acid replacements leading to temperature-sensitive defects of the NS1 protein of influenza A virus. Arch. Virol. 140, 945-950.
72. NORTON, G.P., TANAKA, T., TOBITA, K., NAKADA, S., BUONAGURIO, D.A., GREENSPAN, D., KRYSTAL, M., and PALESE, P. (1987). Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology 156, 204-213.
73. WANG, W., and KRUG, R.M. (1996). The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223, 41-50.
74. SNYDER, M.H., LONDON, W.T., MAASSAB, H.F., CHANOCK, R.M., and MURPHY, B.R. (1990). A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. Virus Res. 15, 69-83.